Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral Replication

被引:41
|
作者
Abram, Michael E. [1 ]
Ferris, Andrea L. [1 ]
Das, Kalyan [2 ,3 ]
Quinones, Octavio [4 ]
Shao, Wei [5 ]
Tuske, Steven [2 ,3 ]
Alvord, W. Gregory [4 ]
Arnold, Eddy [2 ,3 ]
Hughes, Stephen H. [1 ]
机构
[1] NCI, Ctr Canc Res, HIV Drug Resistance Program, Frederick, MD 21701 USA
[2] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA
[4] Frederick Natl Lab Canc Res, Data Management Serv, Frederick, MD USA
[5] Leidos Frederick Inc, Frederick Natl Lab Canc Res, Adv Biomed Comp Ctr, Frederick, MD USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-ACID SUBSTITUTIONS; MURINE LEUKEMIA-VIRUS; IN-VITRO; DRUG-RESISTANT; DNA-SYNTHESIS; COMBINATION THERAPY; MISPAIR EXTENSION; 3TC RESISTANCE; LAMIVUDINE; 3TC;
D O I
10.1128/JVI.00302-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The genetic variation in HIV-1 in patients is due to the high rate of viral replication, the high viral load, and the errors made during viral replication. Some of the mutations in reverse transcriptase (RT) that alter the deoxynucleoside triphosphate (dNTP)binding pocket, including those that confer resistance to nucleoside/nucleotide analogs, affect dNTP selection during replication. The effects of mutations in RT on the spectrum (nature, position, and frequency) of errors made in vivo are poorly understood. We previously determined the mutation rate and the frequency of different types of mutations and identified hot spots for mutations in a lacZ alpha (the alpha complementing region of lacZ) reporter gene carried by an HIV-1 vector that replicates using wild-type RT. We show here that four mutations (Y115F, M184V, M184I, and Q151M) in the dNTP-binding pocket of RT that had relatively small effects on the overall HIV-1 mutation rate (less than 3-fold compared to the wild type) significantly increased mutations at some specific positions in the lacZ alpha reporter gene. We also show that changes in a sequence that flanks the reporter gene can affect the mutations that arise in the reporter. These data show that changes either in HIV-1 RT or in the sequence of the nucleic acid template can affect the spectrum of mutations made during viral replication. This could, by implication, affect the generation of drug-resistant mutants and immunological-escape mutants in patients.
引用
收藏
页码:7589 / 7601
页数:13
相关论文
共 50 条
  • [1] Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
    Abram, Michael E.
    Ferris, Andrea L.
    Shao, Wei
    Alvord, W. Gregory
    Hughes, Stephen H.
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 9864 - 9878
  • [2] Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease
    Dunn, Linda L.
    Boyer, Paul L.
    Clark, Patrick K.
    Hughes, Stephen H.
    VIROLOGY, 2013, 444 (1-2) : 241 - 249
  • [3] Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency
    Harrigan, P. Richard
    Sheen, Chih-Wei
    Gill, Vikram S.
    Wynhoven, Brian
    Hudson, Erin
    Lima, Viviane D.
    Lecocq, Pierre
    Aguirre, Rosalia
    Poon, Art F. Y.
    Sluis-Cremer, Nicolas
    AIDS, 2008, 22 (18) : 2501 - 2508
  • [4] Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones
    Dharmaratne, HRW
    Tan, GT
    Marasinghe, GPK
    Pezzuto, JM
    PLANTA MEDICA, 2002, 68 (01) : 86 - 87
  • [5] Subtype-associated differences in HIV-1 reverse transcription affect the viral replication
    Iordanskiy, Sergey
    Waltke, Mackenzie
    Feng, Yanjun
    Wood, Charles
    RETROVIROLOGY, 2010, 7
  • [6] Subtype-associated differences in HIV-1 reverse transcription affect the viral replication
    Sergey Iordanskiy
    Mackenzie Waltke
    Yanjun Feng
    Charles Wood
    Retrovirology, 7
  • [7] Viral evolution in HIV-1 reverse transcriptase in patients receiving a holding regimen with Trizivir® and tenofovir with persistent viral replication
    Llibre, J. M.
    Bonjoch, A.
    Iribarren, J. A.
    Galindo, M. J.
    Martinez-Picado, X.
    Arazo, P.
    Santos, J. R.
    Domingo, P.
    Clotet, B.
    ANTIVIRAL THERAPY, 2007, 12 : S80 - S80
  • [8] INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
    SULLIVAN, JL
    KOUP, RA
    MERLUZZI, VJ
    HARGRAVE, KD
    ADAMS, J
    GROZINGER, K
    ECKNER, RJ
    ROSENTHAL, AS
    CLINICAL RESEARCH, 1991, 39 (02): : A282 - A282
  • [9] INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
    SULLIVAN, JL
    KOUP, RA
    MERLUZZI, VJ
    HARGRAVE, KD
    ADAMS, J
    GROZINGER, K
    ECKNER, RJ
    PEDIATRIC RESEARCH, 1991, 29 (04) : A186 - A186
  • [10] INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
    MERLUZZI, VJ
    HARGRAVE, KD
    LABADIA, M
    GROZINGER, K
    SKOOG, M
    WU, JC
    SHIH, CK
    ECKNER, K
    HATTOX, S
    ADAMS, J
    ROSEHTHAL, AS
    FAANES, R
    ECKNER, RJ
    KOUP, RA
    SULLIVAN, JL
    SCIENCE, 1990, 250 (4986) : 1411 - 1413